Literature DB >> 31403950

Association Between Migraine Headaches and Dementia in More than 7,400 Patients Followed in General Practices in the United Kingdom.

Karel Kostev1, Jens Bohlken2, Louis Jacob3.   

Abstract

BACKGROUND: Most previous studies focusing on the migraine headache-dementia relationship have failed to simultaneously adjust for several common comorbidities.
OBJECTIVE: The goal of this retrospective cohort study was to investigate the association between migraine headaches and dementia in general practices in the UK.
METHODS: The current study sample included patients who received a migraine diagnosis in one of 67 general practices in the UK between January 1997 and December 2016 (index date). Patients without migraine diagnoses were matched 1 : 1 to patients with migraine diagnoses based on propensity scores using a greedy algorithm and derived from the logistic regression using age, sex, index year, and co-diagnoses. The main outcome of the study was the association between migraine headaches and the incidence of dementia within 10 years of the index date.
RESULTS: This study included 7,454 individuals with or without migraine diagnoses. Mean age was 67.7 years (SD = 5.8 years), and 72.9% of patients were women. Within 10 years of the index date, 5.2% of participants with and 3.7% of those without migraine headaches were diagnosed with dementia (log-rank p < 0.001). The respective figures were 5.8% and 3.6% in women (log-rank p < 0.001) and 4.5% and 3.4% in men (log-rank p = 0.722). We observed a positive association between migraine diagnoses and all-cause dementia (hazard ratio [HR] = 1.43) as well as Alzheimer's disease (HR = 1.87). Sensitivity analyses further revealed that these associations were only significant in women (all-cause dementia: HR = 1.65; Alzheimer's disease: HR = 2.27).
CONCLUSION: Migraine diagnoses were positively associated with all-cause dementia and Alzheimer's disease in women.

Entities:  

Keywords:  Dementia; United zzm321990Kingdom; migraine; retrospective cohort study; sex differences

Mesh:

Year:  2019        PMID: 31403950     DOI: 10.3233/JAD-190581

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  7 in total

1.  Migraine Headache and Risk of Dementia in the Atherosclerosis Risk in Communities Neurocognitive Study.

Authors:  Kristen M George; Aaron R Folsom; A Richey Sharrett; Thomas H Mosley; Rebecca F Gottesman; Ali G Hamedani; Pamela L Lutsey
Journal:  Headache       Date:  2020-03-22       Impact factor: 5.887

2.  Migraine and the risk of dementia: a meta-analysis and systematic review.

Authors:  Wei Jiang; Guo-Hua Liang; Jia-Ai Li; Peng Yu; Ming Dong
Journal:  Aging Clin Exp Res       Date:  2022-01-31       Impact factor: 3.636

Review 3.  Cognitive Impairment in Primary and Secondary Headache Disorders.

Authors:  Olivia Begasse de Dhaem; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2022-03-03

4.  Association of Headache Disorders and the Risk of Dementia: Meta-Analysis of Cohort Studies.

Authors:  Huiling Qu; Shida Yang; Zhicheng Yao; Xiaoyu Sun; Huisheng Chen
Journal:  Front Aging Neurosci       Date:  2022-02-11       Impact factor: 5.750

5.  Association between migraine and cognitive impairment.

Authors:  Lihua Gu; Yanjuan Wang; Hao Shu
Journal:  J Headache Pain       Date:  2022-07-26       Impact factor: 8.588

Review 6.  Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits.

Authors:  Mirella Russo; Matteo A De Rosa; Dario Calisi; Stefano Consoli; Giacomo Evangelista; Fedele Dono; Matteo Santilli; Alberto Granzotto; Marco Onofrj; Stefano L Sensi
Journal:  Int J Mol Sci       Date:  2022-09-27       Impact factor: 6.208

7.  Increased risk of all-cause, Alzheimer's, and vascular dementia in adults with migraine in Korea: a population-based cohort study.

Authors:  Kyungduk Hurh; Sung Hoon Jeong; Seung Hoon Kim; Suk-Yong Jang; Eun-Cheol Park; Sung-In Jang
Journal:  J Headache Pain       Date:  2022-08-24       Impact factor: 8.588

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.